Literature DB >> 15307173

Determining control parameters for dendritic cell-cytotoxic T lymphocyte interaction.

Burkhard Ludewig1, Philippe Krebs, Tobias Junt, Helen Metters, Neville J Ford, Roy M Anderson, Gennady Bocharov.   

Abstract

Dendritic cells (DC) are potent immunostimulatory cells facilitating antigen transport to lymphoid tissues and providing efficient stimulation of T cells. A series of experimental studies in mice demonstrated that cytotoxic T lymphocytes (CTL) can be efficiently induced by adoptive transfer of antigen-presenting DC. However, the success of DC-based immunotherapeutic treatment of human cancer, for example, is still limited because the details of the regulation and kinetics of the DC-CTL interaction are not yet completely understood. Using a combination of experimental mouse studies, mathematical modeling, and nonlinear parameter estimation, we analyzed the population dynamics of DC-induced CTL responses. The model integrates a predator-prey-type interaction of DC and CTL with the non-linear compartmental dynamics of T cells. We found that T cell receptor avidity, the half-life of DC, and the rate of CTL-mediated DC-elimination are the major control parameters for optimal DC-induced CTL responses. For induction of high avidity CTL, the number of adoptively transferred DC was of minor importance once a minimal threshold of approximately 200 cells per spleen had been reached. Taken together, our study indicates that the availability of high avidity T cells in the recipient in combination with the optimal application regimen is of prime importance for successful DC-based immunotherapy. Copyright 2004 Wiley-VCH Verlag GmbH & Co.

Entities:  

Mesh:

Year:  2004        PMID: 15307173     DOI: 10.1002/eji.200425085

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

1.  Mathematical models for CFSE labelled lymphocyte dynamics: asymmetry and time-lag in division.

Authors:  Tatyana Luzyanina; Jovana Cupovic; Burkhard Ludewig; Gennady Bocharov
Journal:  J Math Biol       Date:  2013-12-13       Impact factor: 2.259

Review 2.  Mathematical modeling of tumor-immune cell interactions.

Authors:  Grace E Mahlbacher; Kara C Reihmer; Hermann B Frieboes
Journal:  J Theor Biol       Date:  2019-03-02       Impact factor: 2.691

Review 3.  Multiscale modeling for biologists.

Authors:  Martin Meier-Schellersheim; Iain D C Fraser; Frederick Klauschen
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2009 Jul-Aug

4.  Modelling experimental uveitis: barrier effects in autoimmune disease.

Authors:  David Nicholson; Emma C Kerr; Owen G Jepps; Lindsay B Nicholson
Journal:  Inflamm Res       Date:  2012-04-10       Impact factor: 4.575

5.  A systems immunology approach to plasmacytoid dendritic cell function in cytopathic virus infections.

Authors:  Gennady Bocharov; Roland Züst; Luisa Cervantes-Barragan; Tatyana Luzyanina; Egor Chiglintsev; Valery A Chereshnev; Volker Thiel; Burkhard Ludewig
Journal:  PLoS Pathog       Date:  2010-07-22       Impact factor: 6.823

6.  Modeling cancer-immune responses to therapy.

Authors:  L G dePillis; A Eladdadi; A E Radunskaya
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-10-04       Impact factor: 2.745

7.  IFN-gamma-receptor signaling ameliorates transplant vasculopathy through attenuation of CD8+ T-cell-mediated injury of vascular endothelial cells.

Authors:  Beatrice Bolinger; Daniel Engeler; Philippe Krebs; Simone Miller; Sonja Firner; Matthias Hoffmann; Douglas C Palmer; Nicholas P Restifo; Yinghua Tian; Pierre-Alain Clavien; Burkhard Ludewig
Journal:  Eur J Immunol       Date:  2010-03       Impact factor: 5.532

8.  Predicting response to pembrolizumab in metastatic melanoma by a new personalization algorithm.

Authors:  Neta Tsur; Yuri Kogan; Evgenia Avizov-Khodak; Désirée Vaeth; Nils Vogler; Jochen Utikal; Michal Lotem; Zvia Agur
Journal:  J Transl Med       Date:  2019-10-07       Impact factor: 5.531

9.  A model of dendritic cell therapy for melanoma.

Authors:  Lisette Depillis; Angela Gallegos; Ami Radunskaya
Journal:  Front Oncol       Date:  2013-03-19       Impact factor: 6.244

Review 10.  Understanding Experimental LCMV Infection of Mice: The Role of Mathematical Models.

Authors:  Gennady Bocharov; Jordi Argilaguet; Andreas Meyerhans
Journal:  J Immunol Res       Date:  2015-10-21       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.